|
FAM111B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
3.830200E-04 |
| Normal-vs-Stage3 |
1.70974345792274E-14 |
| Normal-vs-Stage4 |
8.24729950998915E-10 |
| Stage1-vs-Stage2 |
1.024260E-02 |
| Stage1-vs-Stage3 |
5.197400E-01 |
| Stage1-vs-Stage4 |
7.875000E-01 |
| Stage2-vs-Stage3 |
3.861800E-02 |
| Stage2-vs-Stage4 |
4.084100E-02 |
| Stage3-vs-Stage4 |
8.293600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.640900E-04 |
| Normal-vs-Asian |
4.19160262055129E-11 |
| Caucasian-vs-AfricanAmerican |
6.386800E-01 |
| Caucasian-vs-Asian |
4.784200E-01 |
| AfricanAmerican-vs-Asian |
4.624800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62814206561279E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.837800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.57959978430711E-10 |
| Normal-vs-Age(81-100Yrs) |
4.045600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.359900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.350800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.476400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.841800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.296600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.264600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.196970E-01 |
| Classical-VS-Follicular |
1.62569957495862E-12 |
| Classical-VS-Other |
4.232800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
8.93099999510483E-08 |
| Tall-VS-Other |
7.658300E-02 |
| Tall-VS-Normal |
7.80969733327197E-11 |
| Follicular-VS-Other |
6.787600E-02 |
| Follicular-VS-Normal |
2.39959999999151E-05 |
| Other-VS-Normal |
3.031600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.24950000346402E-08 |
| N0-vs-N1 |
2.012200E-01 |
|
|
